CDKN1C and IMAGe syndrome: Two other children in the cohort had gain of function changes in the proliferating cell nuclear antigen–binding domain of cyclin dependent kinase inhibitor 1C (CDKN1C) associated with IMAGe syndrome (intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia, genitourinary anomalies) [40].